Public health interventions, priority populations, and the impact of COVID-19 disruptions on hepatitis C elimination among people who have injected drugs in Montreal (Canada): A modeling study.

Charlotte Lanièce Delaunay,Marina B Klein,Arnaud Godin,Joseph Cox,Nadine Kronfli,Bertrand Lebouché,Carla Doyle,Mathieu Maheu-Giroux

The International journal on drug policy（2023）

引用 0|浏览22

暂无评分

摘要

HCV treatment scale-up among all PWID will be required to eliminate HCV in high-incidence and prevalence settings. Achieving elimination by 2030 will entail concerted efforts to restore and enhance pre-pandemic levels of HCV prevention and care.

查看译文

关键词

COVID-19,HCV,HIV,Harm reduction,Injecting drug use,Micro-elimination,People who inject drugs,SARS-CoV-2,Substance use

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要